Company Overview and News


Add LBT
to your dashboard

Headline News

SA-made lab technology set for “busy real-life” testing

2017-09-27 perthnow.com.au
ADELAIDE medical technology company LBT Innovations has installed its advanced laboratory product at St Vincent’s Hospital in Melbourne — the first test of the system in a busy real-life setting.

Australian Medical Technology Company WoundVue Prototype To Be Used At

2017-08-08 devicespace
NEW YORK, Aug. 8, 2017 /PRNewswire/ -- Australian medical technology company LBT Innovations Limited (ASX:LBT) has entered a collaboration agreement with Central Adelaide Local Health Network (CALHN) Vascular and Endovascular Services, to use LBT's novel WoundVue prototype device in the clinical trial, "Predicting outcomes in patients with diabetic foot ulcers and effectiveness of interventions to improve outcomes".

New leadership for SA medical company

2017-07-20 perthnow.com.au
EXPERIENCED company director Kate Costello will take over as chair of ASX-listed South Australian medical technology firm LBT Innovations at the end of the month, replacing the longstanding Bob Finder.

Jobs growth sectors to lead to SA investment boost

2017-05-29 perthnow.com.au
ADELAIDE is fast becoming a magnet for international investment which is being underpinned by four significant growth sectors, says a leading national property analyst.

LBT Innovations Ltd gets ready to raise

2016-11-30 proactiveinvestors.com.au
The halt will remain in place until the opening of trade on Friday 2nd December 2016, or earlier if an announcement is made to the market.

Bendigo Bank's Robert Johanson is battle ready

2016-10-23 theage.com.au
Bendigo and Adelaide Bank chairman Robert Johanson will be on track to clock up more than three decades on the bank's board if he is re-elected at this week's annual meeting. But those pesky proxy advisers, wouldn't you know it, are kicking up a stink. ISS, the bane of many a chairman this annual meeting season, is advising investors to vote against Johanson's re-election, citing his "extremely long tenure" on the board, and his role as a director of Grant Samuel, which has provided advisory services to the bank.

Bendigo Bank's Robert Johanson is battle ready

2016-10-23 smh.com.au
Bendigo and Adelaide Bank chairman Robert Johanson will be on track to clock up more than three decades on the bank's board if he is re-elected at this week's annual meeting. But those pesky proxy advisers, wouldn't you know it, are kicking up a stink. ISS, the bane of many a chairman this annual meeting season, is advising investors to vote against Johanson's re-election, citing his "extremely long tenure" on the board, and his role as a director of Grant Samuel, which has provided advisory services to the bank.

Catherine has her work cut out at Commonwealth Bank

2016-10-12 theage.com.au
What to do about the problems in life insurance will be just one of items on the lengthy "to-do" list awaiting Catherine Livingstone as she slides into the chairman's position at the Commonwealth Bank at the end of this year.

Catherine has her work cut out at Commonwealth Bank

2016-10-12 smh.com.au
What to do about the problems in life insurance will be just one of items on the lengthy "to-do" list awaiting Catherine Livingstone as she slides into the chairman's position at the Commonwealth Bank at the end of this year.

LBT Innovations among ASX % Gainers intra-day

2016-10-11 proactiveinvestors.com.au
Proactive Investors is a global leader in financial news, media, research and events focusing on emerging growth companies across four continents.

US FDA Grants Approval For s APAS

2016-10-10 devicespace
ADELAIDE, Australia, Oct.10, 2016 /PRNewswire/ -- Clever Culture Systems AG (CCS), the Swiss based joint venture between Australian medical technology company LBT  Innovations Limited (ASX:  LBT) and Hettich AG (Switzerland) has received clearance of its 510(k) de novosubmission to the US Food and Drug Administration (FDA) for APAS® as a Class II medical device.

US FDA Grants Approval for LBT's APAS®

2016-10-10 prnewswire
ADELAIDE, Australia, Oct.10, 2016 /PRNewswire/ -- Clever Culture Systems AG (CCS), the Swiss based joint venture between Australian medical technology company LBT  Innovations Limited (ASX:  LBT) and Hettich AG (Switzerland) has received clearance of its 510(k) de novosubmission to the US Food and Drug Administration (FDA) for APAS® as a Class II medical device.

Appendix 3B

2016-05-09 asx.com.au

Appendix 4C - quarterly

2016-04-26 asx.com.au

Half Yearly Report and Accounts

2016-02-29 asx.com.au

Appendix 4C - quarterly

2016-01-29 asx.com.au

Appendix 3B

2015-11-09 asx.com.au

AGM 2015 CEO Presentation

2015-10-21 asx.com.au

Results of Meeting

2015-10-21 asx.com.au